Current Edition


US faces ‘critical moment’ in pricing reform that ‘won’t come again,’ nonprofit founder says after tallying 554 new hikes

With 2021 over, the pharmaceutical industry kicked off the New Year with one of its favorite pastimes: raising the prices on hundreds of branded meds. …

Continue Reading →

Daiichi Sankyo, with tighter focus on oncology, sells 8 aging US cardiovascular drugs to diversifying Cosette

With the acquisition of the U.S. sales and distribution rights of eight cardiovascular drugs from Daiichi Sankyo, Cosette Pharma of New Jersey is making a …

Continue Reading →

US researchers develop tool to improve diagnostic accuracy

The tool has been used to analyse protein variation in diabetes, cancer, cardiovascular disease, neuro and retinal degeneration. A research team at the University at …

Continue Reading →